Dld Asset Management, LP Biomarin Pharmaceutical Inc Transaction History

Dld Asset Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $1.9 Million - $2.55 Million	21,706 Added 129.74%	38,436 $3.74 Million
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $323,720 - $434,520	4,000 Added 31.42%	16,730 $1.73 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $43,544 - $51,378	530 Added 4.34%	12,730 $1.08 Million
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $872,056 - $1.06 Million	12,200 New	12,200 $1.01 Million
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $2.89 Million - $3.25 Million	-38,300 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $2.86 Million - $3.47 Million	38,300 New	38,300 $2.89 Million
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $1.89 Million - $2.95 Million	-23,720 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $51,386 - $69,732	720 Added 3.13%	23,720 $2 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $12,854 - $17,274	200 Added 0.88%	23,000 $1.95 Million
Q3 2019 Nov 12, 2019	SELL	$67.4 - $85.11 $303,300 - $382,995	-4,500 Reduced 16.48%	22,800 $1.54 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $490,134 - $572,790	-6,100 Reduced 18.26%	27,300 $2.34 Million
Q1 2019 May 14, 2019	BUY	$84.2 - $98.62 $1.94 Million - $2.27 Million	23,000 Added 221.15%	33,400 $2.97 Million
Q4 2018 Feb 13, 2019	BUY	$80.14 - $106.07 $833,456 - $1.1 Million	10,400 New	10,400 $886,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.